Introduction {#s1}
============

With the completion of the human Encyclopedia of DNA Elements (ENCODE) project, an arduous task is to elucidate the function of the vast number of regulatory DNA elements identified in the human genome ([@MJV016C20]; [@MJV016C75]). There are millions of regulatory DNA elements in the human genome, such as enhancers (activators), silencers (repressors), promoters, insulators, and locus control regions. These DNA elements play an important role in tissue- and cell-specific gene regulation; however, vast majorities of them have not been characterized experimentally ([@MJV016C3]; [@MJV016C102]; [@MJV016C20]; [@MJV016C58]; [@MJV016C71]; [@MJV016C83]; [@MJV016C17]). In addition, DNA is a double-stranded molecule with polarity ([@MJV016C90]; [@MJV016C20]). The chromatin environments of regulatory DNA elements are usually asymmetrical ([@MJV016C20]; [@MJV016C43]). The role of polarity or orientation in the function of regulatory DNA elements, such as enhancers and insulators, has long been controversial ([@MJV016C5]; [@MJV016C80]; [@MJV016C91]; [@MJV016C93]). Moreover, structural variations such as inversions and duplications are common in human genomes ([@MJV016C70]; [@MJV016C76]), and DNA rearrangements frequently occur in cancers ([@MJV016C77]; [@MJV016C2]). Finally, mammalian genomes contain a large number of gene clusters whose members often have redundant functions. For example, there are \>50 highly-similar *Pcdh* genes organized into three closely-linked clusters, named *Pcdh *α**, *β*, and *γ* gene clusters ([@MJV016C95]; [@MJV016C96]; [@MJV016C94]). The *Pcdh *α** and *γ* clusters are organized into a tandem array of more than a dozen variable exons and a single set of downstream constant exons (Figure [1](#MJV016F1){ref-type="fig"}A), similar to that of the UDP glucuronosyltransferase, immunoglobulin, and T-cell receptor gene clusters ([@MJV016C95]; [@MJV016C102]; [@MJV016C94]). Thus, an efficient method to manipulate DNA fragments in mice is central for investigating gene expression and modeling human diseases. Figure 1Inversion, duplication, and deletion of a DNA fragment in the *Pcdh*α** regulatory region by CRISPR with a pair of sgRNAs. (**A**) Diagram of the *Pcdh*α** gene cluster with a DNA fragment targeted by CRISPR with two sgRNAs. The human *Pcdh*α** gene cluster is organized into a variable region of 15 exons (13 alternate isoforms and 2 ubiquitous isoforms) followed by a constant region of three exons. The locus regulatory region is located downstream. The sgRNA-targeting sequences are underlined. The protospacer adjacent motif (PAM) sequences of NGG are highlighted in red. The positions of the forward and reverse PCR primers are indicated by arrows. (**B**) Inversion of the DNA fragment is indicated by a red arrowhead. Shown are the amplified upstream and downstream junctions as well as their sequences. Deleted bases are indicated by dashes. Mutated bases are shown in yellow italics. Inserted bases are also shown. (**C**) Duplication of the DNA fragment. The sequences at the duplication junctions are shown. (**D**) Deletion of the DNA fragment. PCR products at the deletion junctions are sequenced. The 25-bp inserted T-nucleotides are also shown. The efficiency of inversion, duplication, and deletion is shown under each panel.

Forward genetics by screening for mutants of interests with specific phenotypes has shed insights into many biological processes ([@MJV016C57]), especially in the mouse model ([@MJV016C11]). Reverse genetics with targeted mutations in chosen sequences has become possible since the development of DNA sequencing technology ([@MJV016C9]; [@MJV016C10]). In particular, targeted gene modifications by homologous recombination in mice have produced thousands of knockout mouse lines ([@MJV016C73]; [@MJV016C82]; [@MJV016C9]). In addition, inversion and duplication methods are developed in mice and zebrafish for targeted structural modifications ([@MJV016C103]; [@MJV016C97]; [@MJV016C28]; [@MJV016C99]; [@MJV016C42]). In particular, tandem duplications could be generated from *trans*-allelic recombination involving inter-chromosomal ligation of two concurrent DSBs, each within one of the two homologous chromosomes or chromatids ([@MJV016C97]; [@MJV016C44]). Finally, targeted mutations engineered by sequence-specific nucleases such as zinc finger nucleases (ZFN) and transcription activator-like effector nucleases (TALEN) turn out to be useful for genome editing ([@MJV016C10]). However, these methods are time-consuming and of low efficiency ([@MJV016C101]; [@MJV016C9]; [@MJV016C10]).

Recently, the clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated nuclease (Cas) system emerged to be very efficient in inducing insertion/deletion mutations (indels) or targeted alterations in mammalian genomes ([@MJV016C50]; [@MJV016C31]; [@MJV016C33]). CRISPR repeats were initially identified as mysterious repetitive extragenic palindromic sequences in bacteria 30 years ago ([@MJV016C78]; [@MJV016C34]). These sequences include direct partial palindromic repeats that are interspaced with constant-sized, non-repetitive, spacers ([@MJV016C29]). CRISPR clusters exist in many prokaryotes and often have *Cas* genes located in the vicinity ([@MJV016C35]; [@MJV016C29]). They provide an adaptive immune system for bacteria and archaea to defend themselves against invading viruses, phages, and plasmids ([@MJV016C4]) through directly targeting the matching protospacer of the invader ([@MJV016C53]; [@MJV016C24]). The protospacer adjacent motif (PAM) in the target DNA of the invader is essential for the host CRISPR system to distinguish self/non-self and to license the RNA-guided nuclease (RGN) to cleave the target DNA sequences ([@MJV016C56]; [@MJV016C54]; [@MJV016C1]; [@MJV016C79]). The CRISPR/Cas system can be classified into three types ([@MJV016C48]). In the type II system, Cas9 endonuclease (also known as Cas5 or Csn1) guided by a complex of two non-coding RNAs, the CRISPR RNA (crRNA) and the *trans*-activating crRNA (tracrRNA), in a bilobed structure ([@MJV016C1]; [@MJV016C39]; [@MJV016C59]; [@MJV016C79]), directly cleaves the PAM-containing cognate target DNA at 3-bp upstream to generate double-strand breaks (DSBs) with blunt ends ([@MJV016C56]; [@MJV016C24]; [@MJV016C18]). The complex of the two non-coding RNAs can be programed into a single-guide RNA (sgRNA) ([@MJV016C37]). This sgRNA can guide the Cas9 enzyme to cleave specific sites in mammalian genomes based on principles of Watson-Crick base pairing, generating a blunt-end DSB that is thought to be repaired by the NHEJ DNA repair pathway ([@MJV016C14]; [@MJV016C16]; [@MJV016C38]; [@MJV016C51]). These transformative findings pave the way for unprecedented applications in life science studies ([@MJV016C25]; [@MJV016C45]; [@MJV016C52]; [@MJV016C64]; [@MJV016C66]; [@MJV016C87], [@MJV016C88], [@MJV016C89]; [@MJV016C92]; [@MJV016C100]; [@MJV016C7]; [@MJV016C19]; [@MJV016C26]; [@MJV016C31]; [@MJV016C41]; [@MJV016C60]; [@MJV016C69]; [@MJV016C72]; [@MJV016C104]; [@MJV016C86]; [@MJV016C98]).

Here we developed an efficient simple method for inverting, duplicating, and deleting mammalian DNA fragments of small regulatory elements and large gene clusters by CRISPR/Cas9 with a pair of sgRNAs. Our data suggested that this method could be applied continuously for precise inversions, duplications, and deletions of DNA fragments of any size ranging from a few tens of bp up to a million of bp, and should be very useful for manipulating DNA fragments to control gene expression and to model copy number variations in human diseases.

Results {#s2}
=======

Targeted DNA fragment inversions and duplications by CRISPR with a pair of sgRNAs {#s2a}
---------------------------------------------------------------------------------

We first designed a pair of sgRNAs for two sites flanking a 1272-bp DNA fragment within a 3-kb regulatory region of the *Pcdh*α** gene cluster (Figure [1](#MJV016F1){ref-type="fig"}A and [Supplementary Tables S1 and S2](http://jmcb.oxfordjournals.org/lookup/suppl/doi:10.1093/jmcb/mjv016/-/DC1)) ([@MJV016C67]; [@MJV016C27]). We tested whether efficient inversion of this DNA regulatory element (RE1) could be generated with two DSBs induced by the Cas9 nuclease guided by these two sgRNAs (Figure [1](#MJV016F1){ref-type="fig"}A). Genomic DNA was isolated from the human HEC-1-B cells transfected with plasmids encoding Cas9 and a pair of sgRNAs. Given that DNA inversions have two junctions, we designed two pairs of specific PCR primers near the cleavage sites of Cas9 to identify upstream and downstream inversion junctions (Figure [1](#MJV016F1){ref-type="fig"}B). We found exact inversion of the regulatory DNA element between the two DSBs induced by Cas9 at 3 bp upstream of the PAM sites (Figure [1](#MJV016F1){ref-type="fig"}B). In addition, we also detected indels at both inversion junctions (Figure [1](#MJV016F1){ref-type="fig"}B). Thus, inversions induced by Cas9 with a pair of sgRNAs were probably generated by the Ku70-Ku80 and DNA ligase IV-dependent repair mechanism of non-homologous end joining (NHEJ) ([@MJV016C13]; [@MJV016C36]; [@MJV016C10]).

We next tested whether duplications could also be generated by CRISPR with two sgRNAs and found tandem duplications of DNA fragments between DSBs induced by Cas9 at 3 bp upstream of PAM (Figure [1](#MJV016F1){ref-type="fig"}C). Indels were also detected near the duplication junctions, suggesting that these tandem duplications are generated by NHEJ between two DSBs each located in a homologous chromosome (chromatid) (Figure [1](#MJV016F1){ref-type="fig"}C). Finally, we found DNA fragment deletions generated by a pair of sgRNAs (Figure [1](#MJV016F1){ref-type="fig"}D), consistent with recent studies ([@MJV016C8]; [@MJV016C6]; [@MJV016C32]). Interestingly, we observed a string of templated nucleotides (T nucleotides) in one of the deletion alleles ([@MJV016C55]). Taken together, inversions, duplications, and deletions of a DNA fragment were successfully generated by CRISPR with a pair of sgRNAs.

Inversions of DNA fragments of defined length by CRISPR in mice {#s2b}
---------------------------------------------------------------

To see whether inversions could be generated in mice by CRISPR, we co-injected a pair of sgRNAs into one-cell embryos, for two sites flanking a DNA fragment of 1241 bp, together with the Cas9 mRNA (Figure [2](#MJV016F2){ref-type="fig"}A). We prepared total genomic DNA from a batch of 68 blastocysts cultured *in vitro*. We successfully amplified a DNA fragment with the size equal to the expected upstream inversion junction. Cloning and sequencing confirmed the upstream junction of the inversion event (Figure [2](#MJV016F2){ref-type="fig"}A and [Supplementary Figure S1](http://jmcb.oxfordjournals.org/lookup/suppl/doi:10.1093/jmcb/mjv016/-/DC1)A). Similarly, we amplified and confirmed the sequences of the downstream inversion junction (Figure [2](#MJV016F2){ref-type="fig"}A and [Supplementary Figure S1](http://jmcb.oxfordjournals.org/lookup/suppl/doi:10.1093/jmcb/mjv016/-/DC1)A). In addition, we detected DNA fragment deletions in blastocysts with a pair of sgRNAs ([Supplementary Figure S1](http://jmcb.oxfordjournals.org/lookup/suppl/doi:10.1093/jmcb/mjv016/-/DC1)A). Thus, CRISPR-mediated inversions with a pair of sgRNAs occur in mouse blastocysts. Figure 2Targeted inversions of DNA fragments of different sizes in mice and in human cells. (**A**) Diagram of CRISPR with a pair of sgRNAs for two sites flanking a 1241-bp DNA fragment in the *Pcdh* locus. Shown are inversion junctions amplified by PCR from mouse blastocysts with specific primer pairs. An example of sequence chromatograms of the upstream and downstream junctions is shown. (**B**) Inversion in F0 founder mice genotyped by tail clipping. (**C**) Diagram of inversion of a 960-bp DNA fragment in the *Pcdh* locus. Shown are F0 inversion mice generated by CRISPR with a pair of sgRNAs. The upstream and downstream junctions of inversions were confirmed by PCR and Sanger sequencing. (**D**) Diagram of inversion of a 29401-bp DNA fragment. F0 inversion mice were genotyped by PCR with specific primer pairs and confirmed by Sanger sequencing. (**E**) Germline transmission in mice of the DNA fragment inversion induced by CRISPR with a pair of sgRNAs. Shown is the genotyping of DNA fragment inversion in F1 mice from the crossing of two founder mice. Chromatograms of the upstream and downstream junctions by Sanger sequencing confirmed the germline transmission of inversions in mice. (**F**) Inversion of a short *Pcdh* regulatory element (RE2) in human cells. Each inversion junction in human cells is confirmed by Sanger sequencing. Inversion of 709-bp (**G**) and 6277-bp (**H**) DNA fragments at the *β*-*globin* locus. (**I**) Inversion of an 18142-bp DNA fragment at the *HoxD* locus. (**J**) Inversion of an 80732-bp DNA fragment at the *β*-*globin* locus. (**K**) Inversion of a 256744-bp DNA fragment spanning the *Pcdh*α** gene cluster. (**L**) Inversion of an 807480-bp DNA fragment spanning the *Pcdh *α**, *β*, and *γ* gene clusters.

To see whether inversion could occur in F0 founder mice, we screened 120 founders and found inversions in 6 mice (5% founders) (Figure [2](#MJV016F2){ref-type="fig"}B and [Supplementary Figure S1](http://jmcb.oxfordjournals.org/lookup/suppl/doi:10.1093/jmcb/mjv016/-/DC1)B). In addition, we found DNA fragment deletion in 26 F0 founder mice (21.7% founders) ([Supplementary Figure S1](http://jmcb.oxfordjournals.org/lookup/suppl/doi:10.1093/jmcb/mjv016/-/DC1)C), consistent with recent studies ([@MJV016C23]; [@MJV016C87]). Finally, we detected indels at the two targeted sites in 13 out of the 15 mice examined ([Supplementary Figure S2](http://jmcb.oxfordjournals.org/lookup/suppl/doi:10.1093/jmcb/mjv016/-/DC1)), consistent with previous studies ([@MJV016C87]).

To further demonstrate the applicability of inversion by CRISPR with two sgRNAs in other sites of the mouse genome, we co-injected Cas9 mRNA with another pair of sgRNAs separated by 960 bp (Figure [2](#MJV016F2){ref-type="fig"}C). Strikingly, we found eight inversions in eight F0 founder mice (100% founders) (Figure [2](#MJV016F2){ref-type="fig"}C and [Supplementary Figure S3](http://jmcb.oxfordjournals.org/lookup/suppl/doi:10.1093/jmcb/mjv016/-/DC1)A). Out of these eight F0 founder mice, we found six mice also with alleles of DNA fragment deletion (75% founders) ([Supplementary Figure S3](http://jmcb.oxfordjournals.org/lookup/suppl/doi:10.1093/jmcb/mjv016/-/DC1)B). Finally, we tested a pair of sgRNAs separated by about 30 kb and obtained 2 mice with inversions and 5 mice with deletions out of 26 mice examined (7.7% inversion and 19.2% deletion in founders) (Figure [2](#MJV016F2){ref-type="fig"}D and [Supplementary Figure S4](http://jmcb.oxfordjournals.org/lookup/suppl/doi:10.1093/jmcb/mjv016/-/DC1)). Together, we demonstrated that founder mice with inversions and deletions of DNA fragments of different sizes can be efficiently generated by CRISPR with a pair of sgRNAs.

Efficient germline transmission of DNA fragment inversion in mice {#s2c}
-----------------------------------------------------------------

The high efficiency of founder mice with inversions and deletions encouraged us to investigate whether these CRISPR alleles could be germline transmitted. We crossed founder mice of inversion with deletion for the *Pcdh* locus 1 (Figure [2](#MJV016F2){ref-type="fig"}B and [Supplementary Figure S5](http://jmcb.oxfordjournals.org/lookup/suppl/doi:10.1093/jmcb/mjv016/-/DC1)A). In a litter of seven F1 mice, we found germline transmissions of two mice with DNA fragment inversions (Figure [2](#MJV016F2){ref-type="fig"}E) and of one mouse with DNA fragment deletions ([Supplementary Figure S5](http://jmcb.oxfordjournals.org/lookup/suppl/doi:10.1093/jmcb/mjv016/-/DC1)B). Sequencing confirmed the germline transmission for inversion in two F1 mice (28.6%) and for deletion in one F1 mouse (14.3%) ([Supplementary Figure S5](http://jmcb.oxfordjournals.org/lookup/suppl/doi:10.1093/jmcb/mjv016/-/DC1)C). In another two litters of F1 mice from F0 founders with deletions of a different DNA fragment, we detected the germline transmission of five different deletion alleles ([Supplementary Figure S5](http://jmcb.oxfordjournals.org/lookup/suppl/doi:10.1093/jmcb/mjv016/-/DC1)D and E). Thus, we demonstrated for the first time that DNA fragment inversions and deletions by CRISPR with a pair of sgRNAs can be transmitted through germline in mice.

Efficient inversions of a repertoire of human DNA fragments with defined length {#s2d}
-------------------------------------------------------------------------------

To investigate whether inversions of DNA fragments have size limitations, we designed seven pairs of sgRNAs to invert DNA fragments on three different human chromosomes ranging in size from as small as 35 bp to as large as 807480 bp in the HEK293T cell line (Figure [2](#MJV016F2){ref-type="fig"}F--L and [Supplementary Table S2](http://jmcb.oxfordjournals.org/lookup/suppl/doi:10.1093/jmcb/mjv016/-/DC1)). These include regulatory DNA elements of 35 bp in the *Pcdh* locus (RE2: regulatory element 2) (Figure [2](#MJV016F2){ref-type="fig"}F and [Supplementary Figure S6](http://jmcb.oxfordjournals.org/lookup/suppl/doi:10.1093/jmcb/mjv016/-/DC1)A) and of 709 bp (Figure [2](#MJV016F2){ref-type="fig"}G and [Supplementary Figure S6](http://jmcb.oxfordjournals.org/lookup/suppl/doi:10.1093/jmcb/mjv016/-/DC1)B) and 6277 bp (Figure [2](#MJV016F2){ref-type="fig"}H and [Supplementary Figure S6](http://jmcb.oxfordjournals.org/lookup/suppl/doi:10.1093/jmcb/mjv016/-/DC1)C) in the *β*-*globin* locus, as well as large gene clusters of *HoxD* (18142 bp), *β*-*globin* (80732 bp), and *Pcdh* (256744 and 807480 bp) (Figure [2](#MJV016F2){ref-type="fig"}I--L and [Supplementary Figure S6](http://jmcb.oxfordjournals.org/lookup/suppl/doi:10.1093/jmcb/mjv016/-/DC1)D--G). Sequencing of both upstream and downstream junctions for each inverted DNA fragment demonstrated that all of the inversion junctions contain precise ligations except those of the *Pcdh* RE2 (Figure [2](#MJV016F2){ref-type="fig"}F and [Supplementary Figure S6](http://jmcb.oxfordjournals.org/lookup/suppl/doi:10.1093/jmcb/mjv016/-/DC1)A) and the upstream junction of the *β*-*globin* locus (Figure [2](#MJV016F2){ref-type="fig"}J and [Supplementary Figure S6](http://jmcb.oxfordjournals.org/lookup/suppl/doi:10.1093/jmcb/mjv016/-/DC1)E). The imprecise junctions of the seven inversions were also detected at these loci, including micro-deletions, micro-insertions, and mutations ([Supplementary Figure S6](http://jmcb.oxfordjournals.org/lookup/suppl/doi:10.1093/jmcb/mjv016/-/DC1)A--G), suggesting a mechanism of NHEJ. Together, we concluded that CRISPR-induced precise inversions could be achieved for DNA fragments in size ranging from about three dozens of bp to a million of bp and that precise inversions could occur in distinct loci on different chromosomes in human cells.

Segmental duplications by CRISPR with a pair of sgRNAs in mice and human cells {#s2e}
------------------------------------------------------------------------------

There are two scenarios for generating DNA fragment deletions from two concurrent DSBs: intra-chromosomal recombination between two DSBs on a single chromosome and *trans*-allelic recombination between two DSBs each on one of the two homologous chromosomes (chromatids) (Figure [3](#MJV016F3){ref-type="fig"}A). In the second scenario, a tandem (segmental) duplication will simultaneously be generated by *trans*-allelic recombination between the two DSBs (Figure [3](#MJV016F3){ref-type="fig"}A) ([@MJV016C97]; [@MJV016C44]). To see whether segmental duplication could be generated by CRISPR with a pair of sgRNA, we first designed a pair of PCR primers to amplify the duplication junction and screened 26 F0 founder mice with DNA fragment deletions. We found one founder mouse with the expected duplication junction and confirmed the junction by Sanger sequencing (Figure [3](#MJV016F3){ref-type="fig"}B and [Supplementary Figure S7](http://jmcb.oxfordjournals.org/lookup/suppl/doi:10.1093/jmcb/mjv016/-/DC1)A). We then designed a pair of flanking PCR primers to amplifying the entire duplicated region. Restriction enzyme digestion of the duplicated region generates three fragments with expected size (Figure [3](#MJV016F3){ref-type="fig"}B). Finally, Sanger sequencing of the entire duplication region confirmed the segmental duplication (Figure [3](#MJV016F3){ref-type="fig"}C). In particular, Sanger sequencing with either forward or reverse primers, upstream of the sgRNA2 target site or downstream of the sgRNA1 target site, respectively, generated the expected chromatogram degeneracy (Figure [3](#MJV016F3){ref-type="fig"}C). Together, these data definitively demonstrated for the first time that segmental duplication occurs in mice by CRISPR with a pair of sgRNAs. Figure 3Segmental duplications by CRISPR through *trans*-allelic recombination in mice and human cells. (**A**) Diagram of CRISPR-mediated duplication by *trans*-allelic recombination between two DSBs in homologous chromosomes (chromatids). (**B**) The duplication junction (F2+R1 primer pair) as well as the entire length of segmental duplicated region (F1+R2 primer pair) were amplified from F0 mice. The segmental duplication was first confirmed by the *Age*I digestion, resulting in three fragments. (**C**) The entire fragment of segmental duplication was confirmed by Sanger sequencing. (**D**) Duplication of a 6277-bp DNA fragment at the *β*-*globin* locus in human cells. Duplication junctions were identified by PCR with a pair of specific primers. An example of sequence chromatograms at the duplication junction is shown. (**E**) Duplication of an 80732-bp DNA fragment at the *β*-*globin* locus. (**F**) Duplication of a 256744-bp DNA fragment spanning the *Pcdh*α** gene cluster. (**G**) Duplication of an 807480-bp DNA fragment spanning the *Pcdh *α**, *β*, and *γ* gene clusters.

To investigate whether segmental duplications could also be generated in human HEK293T cells by CRISPR, we designed PCR primer pairs to detect segmental duplications in the seven loci examined above and identified duplication junctions in four loci (Figure [3](#MJV016F3){ref-type="fig"}D--G). By cloning and sequencing, we confirmed precise junctions of segmental duplications (Figure [3](#MJV016F3){ref-type="fig"}D--G). The imprecise junctions of indels were also detected at these four loci ([Supplementary Figure S7](http://jmcb.oxfordjournals.org/lookup/suppl/doi:10.1093/jmcb/mjv016/-/DC1)B--E). We also detected DNA fragment deletions ([Supplementary Figures S8 and S9](http://jmcb.oxfordjournals.org/lookup/suppl/doi:10.1093/jmcb/mjv016/-/DC1)). Interestingly, in addition to indels, we observed precise deletions in all of the seven loci tested ([Supplementary Figures S8 and S9](http://jmcb.oxfordjournals.org/lookup/suppl/doi:10.1093/jmcb/mjv016/-/DC1)). These data suggest that precise segmental duplications and deletions could be generated by CRISPR with a pair of sgRNAs.

Frequencies of inversions and duplications by CRISPR {#s2f}
----------------------------------------------------

We estimated the frequencies of inversion and duplication events by a quantification method to correct differences in PCR efficiencies of primer pairs, similar to that of the chromosome conformation capture method ([@MJV016C30]; [@MJV016C27]). First, templates for each PCR fragment were amplified and quantified. After mixing equal molar of all templates, a standard curve was generated by quantitative PCR (qPCR) for each pair of primers with a series of dilutions. Six days after transfecting HEK293T cells with plasmids encoding Cas9 and a pair of sgRNAs, the amount of the inverted or duplicated DNA fragments was estimated by fitting on the standard curves. The efficiencies of inversions, duplications, and deletions at these loci ranged from 0.71% to 23.28%, 0.17% to 5.97%, and 0.47% to 34.49%, respectively (Table [1](#MJV016TB1){ref-type="table"}). These efficiencies are much higher than those of gene targeting by homologous recombination or by ZFN and TALEN ([@MJV016C97]; [@MJV016C44]). Potential off-target sites of sgRNAs were predicted by searching the human genome sequences ([Supplementary Table S3](http://jmcb.oxfordjournals.org/lookup/suppl/doi:10.1093/jmcb/mjv016/-/DC1)) ([@MJV016C51]; [@MJV016C87]; [@MJV016C46]). We tested some candidates by PCR with specific primer pairs ([Supplementary Table S1](http://jmcb.oxfordjournals.org/lookup/suppl/doi:10.1093/jmcb/mjv016/-/DC1)). After sequencing, we did not find any modification in these potential off-target sites ([Supplementary Table S4](http://jmcb.oxfordjournals.org/lookup/suppl/doi:10.1093/jmcb/mjv016/-/DC1)). Table 1The efficiency of inversions, duplications, and deletions by CRISPR with a pair of sgRNAs.DNA fragment*β*-*globin* RE1*Pcdh* RE1*β*-*globin* RE2*HoxD* locus*β*-*globin* locus*Pcdhα* cluster*Pcdh α, β*, and *γ* clusters(size in bp)(709)(1272)(6277)(18142)(80732)(256744)(807480)Inversion (%)21.12 ± 4.9923.28 ± 2.4223.13 ± 1.137.28 ± 1.605.96 ± 0.285.48 ± 0.370.71 ± 0.12Duplication (%)ND0.23 ± 0.125.30 ± 1.19ND5.97 ± 0.330.61 ± 0.020.17 ± 0.03Deletion (%)28.33 ± 6.1917.51 ± 1.0434.49 ± 3.579.15 ± 0.1113.39 ± 0.808.46 ± 0.240.47 ± 0.08[^2]

Combinatorial inversions and duplications by CRISPR with four sgRNAs {#s2g}
--------------------------------------------------------------------

To investigate whether combinatorial inversions and duplications could be generated by CRISPR with multiple sgRNAs, we used four sgRNAs targeting the *Pcdh* clusters in HEK293T cells. These four sgRNAs were designed to target specific sites at the boundaries of the *Pcdh *α**, *β*, and *γ* gene clusters (Figure [4](#MJV016F4){ref-type="fig"}A). PCR with specific primer pairs was used to detect six combinatorial inversions of DNA fragments induced by CRISPR (Figure [4](#MJV016F4){ref-type="fig"}B--G). Upstream and downstream junctions for each inversion event were analyzed by PCR and sequencing. We detected inversion junctions of individual **α** (Figure [4](#MJV016F4){ref-type="fig"}B), *β* (Figure [4](#MJV016F4){ref-type="fig"}C), or *γ* (Figure [4](#MJV016F4){ref-type="fig"}D) gene cluster as well as of combinations of these clusters, such as the *Pcdh *α**/*β* (Figure [4](#MJV016F4){ref-type="fig"}E), *β*/*γ* (Figure [4](#MJV016F4){ref-type="fig"}F), or the entire *Pcdh *α**/*β*/*γ* gene clusters (Figure [4](#MJV016F4){ref-type="fig"}G). We confirmed the combinatorial inversion junctions by Sanger sequencing ([Supplementary Figure S10](http://jmcb.oxfordjournals.org/lookup/suppl/doi:10.1093/jmcb/mjv016/-/DC1)). Therefore, combinatorial inversions of large DNA fragments of the *Pcdh* gene clusters can be generated by CRISPR with four sgRNAs. Figure 4Combinatorial genomic inversions and duplications by CRISPR with four sgRNAs. (**A**) Diagram of CRISPR with four sgRNAs targeted at the *Pcdh *α**, *β*, and *γ* gene clusters. Shown are the inversions of the *Pcdh *α** (**B**), *β* (**C**), *γ* (**D**), **α**/*β* (**E**), *β*/*γ* (**F**), and **α**/*β*/*γ* (**G**) gene clusters, as well as segmental duplications of the *Pcdh *α** (**H**), *β* (**I**), *γ* (**J**), **α**/*β* (**K**), *β*/*γ* (**L**), and **α**/*β*/*γ* (**M**). The amplified upstream and downstream inversion junctions or segmental duplication junctions were sequenced. An example of Sanger sequencing chromatograms for each inversion or duplication is shown.

Previous studies revealed that copy number variations by segmental duplications of the *Pcdh* gene clusters are frequent in human populations and may associate with neurodevelopmental diseases or high-order brain functions ([@MJV016C61]; [@MJV016C68]; [@MJV016C85]). Interestingly, we also detected segmental duplications generated by *trans*-allelic recombination between two concurrent DSBs induced by Cas9 with combinations of all four sgRNAs (Figure [4](#MJV016F4){ref-type="fig"}H--M). Specifically, segmental duplication junctions of individual *Pcdh *α**, *β*, or *γ* gene cluster were amplified by PCR and confirmed by Sanger sequencing ([Supplementary Figure S11](http://jmcb.oxfordjournals.org/lookup/suppl/doi:10.1093/jmcb/mjv016/-/DC1)). In addition, segmental duplication junctions of the **α**/*β* or *β*/*γ* gene clusters were also detected as well as potential duplication of all three *Pcdh *α**/*β*/*γ* gene clusters. Finally, we detected indels at the duplication junctions ([Supplementary Figure S11](http://jmcb.oxfordjournals.org/lookup/suppl/doi:10.1093/jmcb/mjv016/-/DC1)), suggesting that the segmental duplications are generated by NHEJ.

In addition to inversions and duplications, six combinatorial deletions by CRISPR were also identified and confirmed by Sanger sequencing. Both precise and imprecise deletion junctions were found at the cleavage site induced by Cas9 ([Supplementary Figures S12 and S13](http://jmcb.oxfordjournals.org/lookup/suppl/doi:10.1093/jmcb/mjv016/-/DC1)). In summary, we found combinatorial inversions, duplications, and deletions generated by CRISPR with four sgRNAs. Their efficiencies range from 0.550% to 8.574%, 0.228% to 6.347%, and 0.318% to 20.989%, respectively ([Supplementary Table S5](http://jmcb.oxfordjournals.org/lookup/suppl/doi:10.1093/jmcb/mjv016/-/DC1)). These data suggest that this efficient CRISPR method may be useful to model human diseases due to segmental DNA fragment variations.

Single-cell screening for DNA fragment inversion, duplication, and deletion by CRISPR {#s2h}
-------------------------------------------------------------------------------------

We screened single-cell CRISPR clones for inversions, duplications, and deletions of the *β*-*globin* RE1, *Pcdh* enhancer, *β*-*globin* RE2, and *HoxD* cluster, and found that they have high efficiency in cultured human cells ([Supplementary Table S6](http://jmcb.oxfordjournals.org/lookup/suppl/doi:10.1093/jmcb/mjv016/-/DC1)). Specifically, for the 709-bp DNA fragment of the *β*-*globin* RE1, from a total of 78 single-cell clones isolated from limiting dilutions of cells transfected with Cas9 and a pair of sgRNAs, we obtained 38 clones with at least one inversion allele and 46 clones with at least one deletion alleles. Thus, the inversion and deletion efficiencies per cell are 48.72% and 58.97%, respectively. However, we did not find any clone with duplications. For the 1272-bp DNA fragment of the *Pcdh* enhancer, the inversion and deletion frequencies per cell were 12.50% and 37.50%, respectively. For the 6277-bp DNA fragment of the *β*-*globin* RE2, the inversion and deletion frequencies were 50.00% and 72.58%, respectively. In this case, we detected one clone with duplication. Finally, for the 18142-bp DNA fragment from the *HoxD* locus, the inversion and deletion frequencies per cell were 0.89% and 3.57%, respectively. These frequencies are much higher than those obtained by homologous recombination or by ZFN and TALEN ([@MJV016C97]; [@MJV016C44]). This suggests that one should be able to easily obtain inversion and deletion clones by CRISPR with a pair of sgRNAs.

A new role of the Pcdh*α* regulatory element in the regulation of the Pcdhγ cluster {#s2i}
-----------------------------------------------------------------------------------

To demonstrate the usefulness of the CRISPR-mediated inversions and deletions in manipulating regulatory DNA elements, we transfected Hec-1-B cells (which is triploid for the *Pcdh* locus) with a pair of sgRNAs for two sites flanking a DNA fragment within a known *Pcdh*α** enhancer ([@MJV016C67]) and screened for single-cell CRISPR clones with deletion and inversion alleles. After screening 51 single-cell clones, we obtained a CRISPR cell line with one inversion and one deletion alleles (Figure [5](#MJV016F5){ref-type="fig"}A and [Supplementary Figure S14](http://jmcb.oxfordjournals.org/lookup/suppl/doi:10.1093/jmcb/mjv016/-/DC1)A). Because Hec-1-B cells express two 'alternate isoforms' (**α*6* and **α*12* variable genes) of the *Pcdh*α** gene cluster ([@MJV016C81]; [@MJV016C27]), we measured expression levels of these two *Pcdh*α** genes in the CRISPR cell lines. Quantitative real-time RT--PCR experiments revealed a significant decrease of their expression levels compared with the wild-type (WT) control (Figure [5](#MJV016F5){ref-type="fig"}B). Surprisingly, the expression of the two ubiquitous isoforms of the *Pcdh*α** cluster is significantly increased (Figure [5](#MJV016F5){ref-type="fig"}B), probably because the targeted element contains a NRSF/REST suppressor binding site ([@MJV016C40]). Interestingly, this element also regulates expression members of the *Pcdh β* and *γ* clusters (Figure [5](#MJV016F5){ref-type="fig"}B). Figure 5The application of inversion and deletion by CRISPR to an enhancer of the *Pcdh*α** gene cluster reveals a new role in the regulation of the *Pcdhγ* cluster. (**A**) Single-cell Hec-1-B clone with enhancer deletion and inversion alleles obtained by CRISPR with a pair of sgRNAs. (**B**) Significant decreases of the *Pcdh *α*6*, *α12*, *β3*, *β9*, *γb5*, and *γc3* gene expression in enhancer-deleted and inverted CRISPR cell line. (**C**) Enhancer deletion in F1 mice. Expression profiles of *Pcdh *α** (**D**) and *γ* (**E**) clusters were measured by real-time RT--PCR using mouse brain tissues. Statistical analysis was performed by Student\'s *t*-test from three independent experiments.

To further investigate mechanisms of *Pcdh* gene regulation, we generated mice with deletions of the NRSF/REST binding site (473 bp deletion) as well as the large deletion of 1241 bp region (Figure [5](#MJV016F5){ref-type="fig"}C and [Supplementary Figure S14](http://jmcb.oxfordjournals.org/lookup/suppl/doi:10.1093/jmcb/mjv016/-/DC1)B). Expression analysis revealed similar patterns of expression changes to previous large deletions of the 3 kb enhancer region (Figure [5](#MJV016F5){ref-type="fig"}D) ([@MJV016C40]). Surprisingly, we found significant expression changes of members of the *Pcdhγ* gene cluster, suggesting a new role of this element in the regulation of the *Pcdhγ* gene cluster (Figure [5](#MJV016F5){ref-type="fig"}E). Together, these experiments demonstrated the usefulness of DNA fragment inversion and deletion by CRISPR in human cells and mice.

Discussion {#s3}
==========

Since the discovery that one bacterial Cas9 enzyme and a single synthetic RNA molecule are the only two required heterologous components for achieving targeted genome editing in human cells ([@MJV016C16]; [@MJV016C38]; [@MJV016C51]), CRISPR/Cas9 technology has rapidly been utilized in broad engineering and biology, such as genetics, synthetic biology, neurosciences, and tumor biology ([@MJV016C50]; [@MJV016C19]; [@MJV016C31]; [@MJV016C33]; [@MJV016C63]). Here we found that DNA fragment inversions ranging from 35 to 807480 bp can easily be achieved in human cells and mice by CRISPR. In addition, segmental duplications can also be achieved by *trans*-allelic recombination between two DSBs induced by Cas9 with a pair of sgRNAs. Moreover, by using four sgRNAs targeting to the *Pcdh* gene clusters, we showed that combinatorial inversions and duplications of the *Pcdh* *α*, *β*, and *γ* gene clusters can be easily achieved in human cells. Finally, we demonstrated for the first time that mice with germline transmission of DNA fragment inversions can be obtained by injecting embryos with Cas9 mRNA and a pair of sgRNAs. These data demonstrated the usefulness of CRISPR technology in manipulating mammalian genomes to study gene regulatory elements as well as gene clusters.

Gene targeting technology in mice through homologous recombination has revolutionized mammalian biology ([@MJV016C9]). Gene editing utilizing NHEJ with artificial DSBs induced by ZFN, TALEN, or CRISPR has advanced rapidly ([@MJV016C10]; [@MJV016C19]; [@MJV016C31]). Although ZFN and TALEN are powerful and effective, their usage is limited because of intrinsic difficulty of protein design and validation. In addition, laborious construction of a different fusion nuclease is required for each targeting site ([@MJV016C10]; [@MJV016C19]; [@MJV016C33]). However, owning to its simplicity, reliability, and easiness to design, CRISPR has emerged as the method of choice for targeted genome engineering in various species ([@MJV016C50]; [@MJV016C31]; [@MJV016C33]).

Our method of generating DNA fragment inversions and duplications in cultured cells and mice by CRISPR/Cas9 is simple and efficient. The efficiency of inversions and duplications by CRISPR/Cas9 is much higher than those obtained by methods through recombinases and nucleases ([@MJV016C65]; [@MJV016C97]; [@MJV016C44]; [@MJV016C28]), paving the way for efficient DNA fragment inversion and duplication in mice *in vivo*. Owning to the high efficiency of generating blunt end by Cas9, we showed that precise inversion and duplication of DNA fragments with defined length ranging in size from tens of bp to hundreds of kb could be easily achieved. When designing experiments for DNA fragment editing in mammalian genomes, one should try to target both sgRNAs to G/C-rich sites in DNaseI hypersensitive regions. On one hand, editing of small DNA fragments could be applied to millions of regulatory DNA elements such as enhancers and insulators in the human genome, which are usually several hundred bp long and occupied asymmetrically by a variety of regulatory protein complexes ([@MJV016C20]; [@MJV016C43]; [@MJV016C75]). On the other hand, editing of large DNA fragments of several hundred kb could be used to study complex gene clusters or to model DNA segmental duplications, which are common in mammalian genomes ([@MJV016C62]). For example, genome editing of inversion of a large DNA fragment by Cre recombinase has shed light on the regulatory landscape of the *HoxD* cluster ([@MJV016C74]). Finally, potential unintended modification from off-target sites could be alleviated by engineering Cas9 enzymes or using truncated sgRNAs, as well as using orthogonal Cas9 nucleases with different specificities ([@MJV016C21]; [@MJV016C49]; [@MJV016C66]; [@MJV016C22]; [@MJV016C31]; [@MJV016C59]; [@MJV016C72]).

Mammals have evolved many mechanisms to repair DSBs, among which NHEJ and HR are the major pathways to maintain genome stability ([@MJV016C13]; [@MJV016C36]). DSBs repaired by HR are essential for meiotic recombination during meiosis, whereas DSBs repaired by NHEJ are essential for DNA rearrangement during normal mammalian immune development ([@MJV016C13]). The blunt-ended DSBs generated by Cas9 are usually repaired by NHEJ ([@MJV016C10]). Since we detected both precise inversions and inversions with small indels, they are most likely resulted from NHEJ. An 'alternative end joining' repair pathway, known as microhomology-mediated end joining (MMEJ), involves short repeats of 4--25 bp near the DSBs and causes genomic deletions, inversions, and other DNA rearrangements ([@MJV016C55]). For the human *Pcdh* RE2, we observed that the inversion is from the downstream microhomology repeat of 'CTGG' to the upstream double-strand breakpoint. For the mouse *Pcdh* locus 1, we observed that the downstream inversion junctions in two mice have deletions near a 6-bp inverted repeat of 'CTAGAA' ([Supplementary Figure S1](http://jmcb.oxfordjournals.org/lookup/suppl/doi:10.1093/jmcb/mjv016/-/DC1)B). Finally, for the mouse *Pcdh* locus 2, we observed that the upstream inversion junctions in five mice have deletions near a 7-bp inverted repeat of 'GGGTGGT' ([Supplementary Figure S3](http://jmcb.oxfordjournals.org/lookup/suppl/doi:10.1093/jmcb/mjv016/-/DC1)A). In all these cases, DSBs induced by Cas9 near the inverted microhomologous repeats stimulate the inversions of DNA fragments. Thus, these inversions are likely resulted from MMEJ.

Cas9 guided by multiple sgRNAs causes simultaneous multiplexed genome editing in cultured cells and mice ([@MJV016C16]; [@MJV016C87]). Furthermore, large chromosomal rearrangements can also be obtained in human cells through CRISPR ([@MJV016C15]; [@MJV016C47]; [@MJV016C84]). Given the complex nature of detected combinatorial inversions and duplications of the *Pcdh* gene clusters with four sgRNAs, attention should be paid to potential combinations of complex genome rearrangements by CRISPR with multiple sgRNAs. Finally, our observation of combinatorial inversions, duplications, and deletions by CRISPR with four sgRNAs is consistent with the idea that all of the ends of DSBs induced by Cas9 with multiple sgRNAs are brought into a single giga-Dalton repair center and ligated stochastically ([@MJV016C36]).

In summary, precise inversions, duplications, and deletions of DNA fragments of variable sizes could be easily generated in mammals with Cas9 guided by two sgRNAs. In addition, multiplex targeted genomic inversions, duplications, and deletions of very large gene clusters could easily be obtained. This CRISPR method should be useful in mammalian genome engineering for studying millions of regulatory DNA elements as well as large gene clusters whose members often have redundant functions.

Materials and methods {#s4}
=====================

Construction of targeting sgRNA vectors {#s4a}
---------------------------------------

A pair of complementary oligos ([Supplementary Table S1](http://jmcb.oxfordjournals.org/lookup/suppl/doi:10.1093/jmcb/mjv016/-/DC1)) for each CRISPR targeting sgRNA was annealed with 5′ overhangs of 'ACCG' and 'AAAC'. The annealed DNA is inserted into a BsaI-linearized pGL3 vector with the U6 promoter ([@MJV016C72]). SgRNA sequences were designed to target specific genomic sites ([Supplementary Table S2](http://jmcb.oxfordjournals.org/lookup/suppl/doi:10.1093/jmcb/mjv016/-/DC1)).

Cell culture, transfection, and PCR analysis {#s4b}
--------------------------------------------

HEK293T cells were maintained in Dulbecco\'s modified Eagle\'s medium (HyClone) supplemented with 10% (*v/v*) FBS (Gibco) and 1% penicillin--streptomycin (Gibco). HEC-1-B cells were maintained in Eagle\'s Minimum Essential Medium (Gibco) supplemented with 10% (*v/v*) FBS (Gibco), 1% penicillin--streptomycin (Gibco), 1 mM sodium pyruvate (Sigma) and 2 mM GlutaMAX (Gibco). Cells were cultured at 37°C in a 5% (*v/v*) CO~2~ incubator. Cells were transfected with the Cas9 (2 μg) ([@MJV016C12]) and sgRNA plasmids (2.5 μg) by Lipofectamine 2000 (Life Technology) 1 day after plating 9 × 10^5^ cells per well in a 6-well plate. On Day 2 post-transfection, puromycin (2 μg/ml) was added and cells were cultured for additional 4 days. After harvesting cells, 80 μl alkaline lysis buffer (25 mM NaOH and 0.2 mM disodium EDTA, pH12.0) was added and heated at 98°C for 40 min. Equal volume of neutralizing buffer (40 mM Tris--HCl, pH5.0) was then added. One microliter was then used as template genomic DNA for PCR in a total volume of 20 μl with a specific pair of primers ([Supplementary Table S1](http://jmcb.oxfordjournals.org/lookup/suppl/doi:10.1093/jmcb/mjv016/-/DC1)) to screen for DNA fragment inversions, duplications, and deletions. The PCR conditions are: predenaturing at 94°C for 4 min; followed by 35 cycles of 94°C denaturing for 30 sec, 60°C annealing for 30 sec, and 72°C extension for 50 sec; followed by a final extension at 72°C for 3 min.

In vitro transcription of Cas9 mRNA and sgRNAs {#s4c}
----------------------------------------------

The Cas9 vector ([@MJV016C12]) with T7 promoter was first linearized with *Xba*I for use as a template for *in vitro* transcription with T7 polymerase. Cas9 mRNA was *in vitro* transcribed using mMESSAGE mMACHINE T7 Ultra Kit according to the manufacturer\'s manual (Life Technologies). SgRNAs templates with T7 promoter were obtained by PCR amplification with primers ([Supplementary Table S1](http://jmcb.oxfordjournals.org/lookup/suppl/doi:10.1093/jmcb/mjv016/-/DC1)). The MEGAshortscript Kit (Life Technologies) was used to transcribe sgRNAs from the PCR product template. Cas9 mRNA and sgRNAs were purified with the MEGAclear Kit (Life Technologies) and eluted in TE buffer (0.2 mM EDTA) for microinjections.

One-cell embryos injection {#s4d}
--------------------------

All mice were housed at 23°C on a 12/12 h light-dark cycle (7:00 am--19:00 pm) in the SPF facilities. All experiments were carried out in accordance with Institutional Animal Care and Use Committee of Shanghai Jiao Tong University. C57BL/6 female mice and ICR mouse strains were used as embryo donors and foster mothers, respectively. Superovulated female C57BL/6 mice (26--30 days old) were mated to the C57BL/6 stud males. After 20 h, mouse embryos were obtained from the oviducts of superovulated female C57BL/6 mice. Cas9 mRNAs (100 ng/μl) and sgRNAs (50 ng/μl) were injected into the cytoplasm of one-cell embryos. Next, the injected embryos were *in vitro* cultured in the Ksom medium (Millipore) for half an hour at 37°C in a 5% CO~2~ incubator. The survivors of the injected embryos were implanted into the oviducts of pseudo-pregnant ICR mice. For blastocysts experiments, the survivors of the injected embryos were *in vitro* cultured in the Ksom medium for 4 days at 37°C in a 5% CO~2~ incubator. The blastocyst embryos of normal development were selected for experiments.

Mouse genotyping for detecting DNA fragment inversions, duplications, and deletions {#s4e}
-----------------------------------------------------------------------------------

The genotyping method was described previously ([@MJV016C97]). PCR was used to identify inversions, duplications, and deletions in mice with appropriate primer pairs ([Supplementary Table S1](http://jmcb.oxfordjournals.org/lookup/suppl/doi:10.1093/jmcb/mjv016/-/DC1)).

Prediction and analysis of potential off-target sites {#s4f}
-----------------------------------------------------

Potential off-target sites of sgRNAs were predicted ([@MJV016C51]). For a 23-nt sequence of sgRNA target and PAM, the first seven nucleotides of sgRNA target sequences allow mismatches and the first nucleotide of PAM (NGG) also allows mismatches. However, thirteen nucleotides of seed sequences of sgRNAs must fully match. Potential off-target sites were searched within the human genome (hg19) and mouse genome (mm9) by a customized Python program. Potential off-target sites were amplified by PCR with specific primer pairs ([Supplementary Table S1](http://jmcb.oxfordjournals.org/lookup/suppl/doi:10.1093/jmcb/mjv016/-/DC1)) and the amplified DNAs were sequenced.

RT--PCR and real-time PCR {#s4g}
-------------------------

Total RNA was prepared from cultured HEC-1-B cells by using TRIzol Reagent (Ambion). The reverse-transcription reactions were carried out by using the Reverse Transcription Systems (Promega) with 1 μg total RNA. The appropriate primers for Real-Time PCR were listed in [Supplementary Table S1](http://jmcb.oxfordjournals.org/lookup/suppl/doi:10.1093/jmcb/mjv016/-/DC1). Statistical analysis was performed by student *t*-test from three independent experiments.

Quantitative PCR analysis of the efficiency for DNA fragment deletions, inversions, and duplications {#s4h}
----------------------------------------------------------------------------------------------------

A q-PCR based method was used to analyze the efficiency of inversions, duplications, and deletions of DNA fragments. Owing to the limitation of q-PCR product length and indels produced by NHEJ-mediated repair of DSBs, the primers flanking each pair of sgRNA target sites were designed at least 50 bp away from the cleavage site of Cas9 and used to amplify an expected PCR product of less than 600 bp. Genomic DNA of transfected cells were used to amplify the PCR products of wild-type (WT), deletion (Del), inversion (Inv), and duplication (Dup) for reference templates. These PCR product templates were first quantified and diluted to equal amount of molars in TE buffer. A series of dilutions of these template DNAs were used to construct a standard curve. The appropriate primers for q-PCR analysis were listed in [Supplementary Table S1](http://jmcb.oxfordjournals.org/lookup/suppl/doi:10.1093/jmcb/mjv016/-/DC1). Q-PCR reactions were performed with the Faststart Universal SYBR Green Master system (Roche) under conditions of 10 min at 95°C for activation, 40 cycles of 15 sec at 95°C and 90 sec at 60°C. The quantities of DNA fragment inversions, duplications, and deletions were obtained by plotting against the standard curve. The efficiencies were calculated using the following formulas: $$\mspace{-180mu}{\%\;{Deletion}} = \text{Del}/({\text{Del} + \text{Inv} + \text{WT} + \text{Dup}})$$ $${\%\;{Inversion}} = \text{Inv~}/({\text{Del} + \text{Inv} + \text{WT} + \text{Dup}})$$ $$\mspace{-1890mu}{\%\;{Duplication}} = \text{Dup}/({\text{Del} + \text{Inv} + \text{WT} + \text{Dup}})$$

Single-cell clone screening {#s4i}
---------------------------

HEK293T cells were cultured and transfected with plasmids encoding Cas9 and two sgRNAs as described above. On Day 2 post-transfection, puromycin (2 μg/ml) was added and continued culturing for additional 4 days. Then cells were cultured in fresh medium for 8 days to grow to confluency before harvesting. To obtain single-cell CRISPR clone, the harvested cells were seeded and cultured in 96-well plates at a density of one cell per well. Positive wells with one single-cell clone were identified on Day 6 and continued culturing for additional 8 days. Single-cell clones were then screened by PCR analyses for inversion, duplication, and deletion events.

Supplementary material {#s5}
======================

[Supplementary material is available at *Journal of Molecular Cell Biology* online](http://jmcb.oxfordjournals.org/lookup/suppl/doi:10.1093/jmcb/mjv016/-/DC1).
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